Sánchez-Pellicer, P.; Boix-RodrÃguez, C.; Hernández-Belmonte, A.; Encarnación-Castellano, C.d.l.; Mendiola-López, A.; Núñez-Delegido, E.; Navarro-Moratalla, L.; Agüera-Santos, J.; Navarro-López, V.; Galán-Llopis, J.A.
Bladder Cancer and Probiotics: What Do We Know So Far? Cancers 2023, 15, 5551.
https://doi.org/10.3390/cancers15235551
AMA Style
Sánchez-Pellicer P, Boix-RodrÃguez C, Hernández-Belmonte A, Encarnación-Castellano Cdl, Mendiola-López A, Núñez-Delegido E, Navarro-Moratalla L, Agüera-Santos J, Navarro-López V, Galán-Llopis JA.
Bladder Cancer and Probiotics: What Do We Know So Far? Cancers. 2023; 15(23):5551.
https://doi.org/10.3390/cancers15235551
Chicago/Turabian Style
Sánchez-Pellicer, Pedro, Claudia Boix-RodrÃguez, Adriana Hernández-Belmonte, Cristina de la Encarnación-Castellano, Alberto Mendiola-López, Eva Núñez-Delegido, Laura Navarro-Moratalla, Juan Agüera-Santos, Vicente Navarro-López, and Juan Antonio Galán-Llopis.
2023. "Bladder Cancer and Probiotics: What Do We Know So Far?" Cancers 15, no. 23: 5551.
https://doi.org/10.3390/cancers15235551
APA Style
Sánchez-Pellicer, P., Boix-RodrÃguez, C., Hernández-Belmonte, A., Encarnación-Castellano, C. d. l., Mendiola-López, A., Núñez-Delegido, E., Navarro-Moratalla, L., Agüera-Santos, J., Navarro-López, V., & Galán-Llopis, J. A.
(2023). Bladder Cancer and Probiotics: What Do We Know So Far? Cancers, 15(23), 5551.
https://doi.org/10.3390/cancers15235551
